Katherine Myall

736 total citations · 1 hit paper
20 papers, 376 citations indexed

About

Katherine Myall is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Infectious Diseases. According to data from OpenAlex, Katherine Myall has authored 20 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 11 papers in Physiology and 4 papers in Infectious Diseases. Recurrent topics in Katherine Myall's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Respiratory and Cough-Related Research (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Katherine Myall is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Respiratory and Cough-Related Research (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Katherine Myall collaborates with scholars based in United Kingdom, Ireland and Canada. Katherine Myall's co-authors include Alex West, Bhashkar Mukherjee, Amy Dewar, Philip L. Molyneaux, Muhunthan Thillai, Giulia Benedetti, Rebecca Preston, Sze Mun Mak, Heather Milburn and Surinder S. Birring and has published in prestigious journals such as The Lancet, CHEST Journal and Thorax.

In The Last Decade

Katherine Myall

19 papers receiving 364 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Persistent Post–COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment

2021 264 citations Katherine Myall, Bhashkar Mukherjee et al. Annals of the American Thoracic Society profile →

Peers

Katherine Myall

NEURO

PRM

CCICM

Amy Dewar United Kingdom

Marvin Balaan United States

Mabel Tong China

Sabina Sahanic Austria

Annalisa Frizzelli Italy

Jowita Biernawska Poland

Tøri Vigeland Lerum Norway

Maitray A. Patel Canada

Е. Д. Баздырев Russia

Zachary Manickas-Hill United States

Amy Dewar United Kingdom

Katherine Myall

218 ×1.0

NEURO

150 ×0.8

PRM

162 ×0.9

43 ×1.0

40 ×1.0

CCICM

Citations per year, relative to Katherine Myall Katherine Myall (= 1×) peers Amy Dewar

Countries citing papers authored by Katherine Myall

Since Specialization

Citations

This map shows the geographic impact of Katherine Myall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Myall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Myall more than expected).

Fields of papers citing papers by Katherine Myall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Myall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Myall. The network helps show where Katherine Myall may publish in the future.

Co-authorship network of co-authors of Katherine Myall

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Myall. A scholar is included among the top collaborators of Katherine Myall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Myall. Katherine Myall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bechman, Katie, Mark Russell, Mark Gibson, et al.. (2025). Incidence, prevalence, and mortality of sarcoidosis in England: a population-based study. The Lancet Regional Health - Europe. 53. 101283–101283. 1 indexed citations

Bechman, Katie, Kai He, Mark Russell, et al.. (2025). Systematic review and meta-analysis of the efficacy of biologic and targeted synthetic therapies in sarcoidosis. Thorax. 80(10). 702–710. 2 indexed citations

MacKay, Emily J., et al.. (2024). Patient Perception of Cough in Interstitial Lung Disease; Impact of Cough Hypersensitivity. Lung. 202(4). 425–430. 2 indexed citations

Myall, Katherine, et al.. (2024). Converging Pathways: A Review of Pulmonary Hypertension in Interstitial Lung Disease. Life. 14(9). 1203–1203. 1 indexed citations

Myall, Katherine, Peter Siu Pan Cho, & Surinder S. Birring. (2024). What causes cough in pulmonary fibrosis, and how should we treat it?. Current Opinion in Pulmonary Medicine. 30(5). 523–529. 1 indexed citations

Hannah, Jennifer, et al.. (2024). Antifibrotic therapy in progressive pulmonary fibrosis: a review of recent advances. Expert Review of Respiratory Medicine. 18(6). 397–407. 5 indexed citations

Myall, Katherine, Alex West, Zhe Wu, et al.. (2023). Nocturnal Hypoxemia Associates With Symptom Progression and Mortality in Patients With Progressive Fibrotic Interstitial Lung Disease. CHEST Journal. 164(5). 1232–1242. 12 indexed citations

Cho, Peter Siu Pan, et al.. (2023). P212 Cough hypersensitivity features in interstitial lung disease. A239–A239.

Myall, Katherine, Alex West, Zhe Wu, et al.. (2023). Treatment of obstructive sleep apnoea in patients with interstitial lung disease improves quality of life and survival. OA2586–OA2586. 1 indexed citations

10.

Myall, Katherine, et al.. (2022). How COVID-19 interacts with interstitial lung disease. Breathe. 18(1). 210158–210158. 9 indexed citations

11.

Myall, Katherine, et al.. (2022). Nocturnal hypoxaemia is associated with mortality in patients with fibrotic interstitial lung disease. 1355–1355. 1 indexed citations

12.

Myall, Katherine, Bhashkar Mukherjee, Giulia Benedetti, et al.. (2021). Persistent Post–COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment. Annals of the American Thoracic Society. 18(5). 799–806. 264 indexed citations breakdown →

13.

Myall, Katherine, et al.. (2021). Identifying patients at risk of post-discharge complications related to COVID-19 infection. Thorax. 76(4). 408–411. 34 indexed citations

14.

Myall, Katherine, Joanne Kavanagh, & Surinder S. Birring. (2019). Idiopathic pulmonary fibrosis-associated cough: Mechanisms and management. Pulmonary Pharmacology & Therapeutics. 56. 100–103. 7 indexed citations

15.

Myall, Katherine, Alex West, & Brian D. Kent. (2019). Sleep and interstitial lung disease. Current Opinion in Pulmonary Medicine. 25(6). 623–628. 5 indexed citations

16.

Myall, Katherine, et al.. (2018). The effect of Rituximab treatment on progression of Rheumatoid arthritis-associated interstitial lung disease. OA3821–OA3821. 2 indexed citations

17.

Myall, Katherine & Heather Milburn. (2017). An update of management of latent tuberculosis infection and active disease in patients with chronic kidney disease. Polskie Archiwum Medycyny Wewnętrznej. 127(10). 681–686. 8 indexed citations

18.

Myall, Katherine, et al.. (2016). P190 Characteristics and outcome of patients with active tuberculosis requiring intensive care admission, 2010–2015. Thorax. 71(Suppl 3). A186.2–A187. 1 indexed citations

19.

Myall, Katherine, et al.. (2012). An unusual cause of high anion gap metabolic acidosis: pyroglutamic acidosis. Critical Care. 16(S1). 1 indexed citations

20.

Myall, Katherine, et al.. (2011). Mind the gap! An unusual metabolic acidosis. The Lancet. 377(9764). 526–526. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact